Search Result "Anetumab ravtansine"


Review Article open access plus

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

Journal: Clinical Cancer Drugs
Volume: 3 Issue: 2 Year: 2016 Page: 76-86
Author(s): Xiao-Yan Zhao,Babu Subramanyam,Nenad Sarapa,Sven Golfier,Harald Dinter

General Review Article

Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 27 Issue: 27 Year: 2020 Page: 4567-4576
Author(s): Shuo Cao,Yue-Hui Dong,De-Feng Wang,Zhao-Peng Liu

Review Article

ADCs, as Novel Revolutionary Weapons for Providing a Step Forward in Targeted Therapy of Malignancies

Journal: Current Drug Delivery
Volume: 17 Issue: 1 Year: 2020 Page: 23-51
Author(s): Nooshafarin Amani,Farid Abedin Dorkoosh,Hamid Mobedi

Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates

Ebook: Topics in Anti-Cancer Research
Volume: 4 Year: 2015
Author(s): Franco Dosio,Barbara Stella,Paola Milla,Carlo Della Pepa,Daniela Gastaldi,Silvia Arpicco
Doi: 10.2174/9781681080765115040003

Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies

Journal: Current Drug Targets
Volume: 17 Issue: 7 Year: 2016 Page: 824-849
Author(s): Stefano Thellung,Roberto E. Favoni,Roberto Würth,Mario Nizzari,Alessandra Pattarozzi,Antonio Daga,Tullio Florio,Federica Barbieri

Malignant Pleural Mesothelioma (MPM): Latent Disease

Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 7 Year: 2016
Author(s): M. Genovés Crespo,F.J. Callejas González,R.D. García Ángel,W. Mayoris Almonte,F.J. Agustín Martínez
Doi: 10.2174/9781681082516116070003

Results 1 - 1 of 6

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy